Dr. Ashwin Rumalla, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- University of Missouri, Kansas City, School of Medicine (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 798
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: University of Missouri, Kansas City, School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
FL license ME84488
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Ocala Ocala, FL
- Marion Communtiy Hospital Ocala, FL
Medical groups
- Endoscopy Center of Ocala Inc (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 798
- Services billed
- 1,293
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 196 | 192 |
| Established patient office or other outpatient visit, 20-29 minutes | 153 | 118 |
| Established patient office or other outpatient visit, 30-39 minutes | 144 | 115 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 114 | 114 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 89 | 87 |
| New patient office or other outpatient visit, 30-44 minutes | 65 | 65 |
| New patient office or other outpatient visit, 45-59 minutes | 65 | 65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 61 | 61 |
| Diagnostic exam of large bowel using a flexible endoscope | 54 | 54 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 45 | 45 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Ocala, FL | 285 |
| Famotidine Other prescribers in Ocala, FL | 166 |
| Pantoprazole Sodium Other prescribers in Ocala, FL | 96 |
| Stelara (ustekinumab) | 30 |
| Mesalamine Other prescribers in Ocala, FL | 30 |
| Ursodiol Other prescribers in Ocala, FL | 28 |
| Gavilyte-C (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Ocala, FL | 25 |
| Azathioprine Other prescribers in Ocala, FL | 23 |
| Ondansetron Odt (ondansetron) Other prescribers in Ocala, FL | 21 |
| Linzess (linaclotide) Other prescribers in Ocala, FL | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 17 payments worth $650 in total to this clinician.
| Janssen Biotech, Inc. | $193 |
|---|---|
| AbbVie Inc. | $159 |
| Boston Scientific Corporation | $142 |
| Regeneron Healthcare Solutions, Inc. | $84.48 |
| Genzyme Corporation | $36.18 |
| Phathom Pharmaceuticals, Inc. | $35.71 |
| Food and Beverage | $650 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.